614 related articles for article (PubMed ID: 20067981)
21. Downregulation of mitogen-activated protein kinase 1 of Leishmania donovani field isolates is associated with antimony resistance.
Ashutosh ; Garg M; Sundar S; Duncan R; Nakhasi HL; Goyal N
Antimicrob Agents Chemother; 2012 Jan; 56(1):518-25. PubMed ID: 22064540
[TBL] [Abstract][Full Text] [Related]
22. Biomarkers of antimony resistance: need for expression analysis of multiple genes to distinguish resistance phenotype in clinical isolates of Leishmania donovani.
Kumar D; Singh R; Bhandari V; Kulshrestha A; Negi NS; Salotra P
Parasitol Res; 2012 Jul; 111(1):223-30. PubMed ID: 22302478
[TBL] [Abstract][Full Text] [Related]
23. Leishmania donovani: effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Indian clinical isolates to sodium stibogluconate.
Valiathan R; Dubey ML; Mahajan RC; Malla N
Exp Parasitol; 2006 Oct; 114(2):103-8. PubMed ID: 16616137
[TBL] [Abstract][Full Text] [Related]
24. Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani.
Samant M; Sahasrabuddhe AA; Singh N; Gupta SK; Sundar S; Dube A
Parasitology; 2007 Aug; 134(Pt 9):1175-84. PubMed ID: 17362540
[TBL] [Abstract][Full Text] [Related]
25. Species-specific antimonial sensitivity in Leishmania is driven by post-transcriptional regulation of AQP1.
Mandal G; Mandal S; Sharma M; Charret KS; Papadopoulou B; Bhattacharjee H; Mukhopadhyay R
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003500. PubMed ID: 25714343
[TBL] [Abstract][Full Text] [Related]
26. Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach.
Kazemi-Rad E; Mohebali M; Khadem-Erfan MB; Saffari M; Raoofian R; Hajjaran H; Hadighi R; Khamesipour A; Rezaie S; Abedkhojasteh H; Heidari M
Exp Parasitol; 2013 Oct; 135(2):344-9. PubMed ID: 23928349
[TBL] [Abstract][Full Text] [Related]
27. A clinical isolate of Leishmania donovani with ITS1 sequence polymorphism as a cause of para-kala-azar dermal leishmaniasis in an Ethiopian human immunodeficiency virus-positive patient on highly active antiretroviral therapy.
Gelanew T; Amogne W; Abebe T; Kuhls K; Hailu A; Schönian G
Br J Dermatol; 2010 Oct; 163(4):870-4. PubMed ID: 20331449
[TBL] [Abstract][Full Text] [Related]
28. The molecular characterization of clinical isolates from Indian Kala-azar patients by MLEE and RAPD-PCR.
Manna M; Majumder HK; Sundar S; Bhaduri AN
Med Sci Monit; 2005 Jul; 11(7):BR220-7. PubMed ID: 15990683
[TBL] [Abstract][Full Text] [Related]
29. Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis.
Bhandari V; Kulshrestha A; Deep DK; Stark O; Prajapati VK; Ramesh V; Sundar S; Schonian G; Dujardin JC; Salotra P
PLoS Negl Trop Dis; 2012; 6(5):e1657. PubMed ID: 22629478
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of proteins in antimony-susceptible and -resistant isolates of Leishmania donovani.
Biyani N; Singh AK; Mandal S; Chawla B; Madhubala R
Mol Biochem Parasitol; 2011 Oct; 179(2):91-9. PubMed ID: 21736901
[TBL] [Abstract][Full Text] [Related]
31. Increased parasite surface antigen-2 expression in clinical isolates of Leishmania donovani augments antimony resistance.
Bhandari V; Kumar D; Verma S; Srividya G; Negi NS; Singh R; Salotra P
Biochem Biophys Res Commun; 2013 Nov; 440(4):646-51. PubMed ID: 24103752
[TBL] [Abstract][Full Text] [Related]
32. Molecular Preadaptation to Antimony Resistance in Leishmania donovani on the Indian Subcontinent.
Dumetz F; Cuypers B; Imamura H; Zander D; D'Haenens E; Maes I; Domagalska MA; Clos J; Dujardin JC; De Muylder G
mSphere; 2018 Apr; 3(2):. PubMed ID: 29669889
[TBL] [Abstract][Full Text] [Related]
33.
Eslami G; Zarchi MV; Moradi A; Hejazi SH; Sohrevardi SM; Vakili M; Khamesipour A
J Vector Borne Dis; 2016; 53(4):370-374. PubMed ID: 28035115
[TBL] [Abstract][Full Text] [Related]
34. Comparative in vivo expression of amastigote up regulated Leishmania genes in three different forms of Leishmaniasis.
Sharma P; Gurumurthy S; Duncan R; Nakhasi HL; Salotra P
Parasitol Int; 2010 Jun; 59(2):262-4. PubMed ID: 19963076
[TBL] [Abstract][Full Text] [Related]
35. Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines.
Ouakad M; Vanaerschot M; Rijal S; Sundar S; Speybroeck N; Kestens L; Boel L; De Doncker S; Maes I; Decuypere S; Dujardin JC
Parasitology; 2011 Sep; 138(11):1392-9. PubMed ID: 21819638
[TBL] [Abstract][Full Text] [Related]
36. Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent.
Imamura H; Downing T; Van den Broeck F; Sanders MJ; Rijal S; Sundar S; Mannaert A; Vanaerschot M; Berg M; De Muylder G; Dumetz F; Cuypers B; Maes I; Domagalska M; Decuypere S; Rai K; Uranw S; Bhattarai NR; Khanal B; Prajapati VK; Sharma S; Stark O; Schönian G; De Koning HP; Settimo L; Vanhollebeke B; Roy S; Ostyn B; Boelaert M; Maes L; Berriman M; Dujardin JC; Cotton JA
Elife; 2016 Mar; 5():. PubMed ID: 27003289
[TBL] [Abstract][Full Text] [Related]
37. Epidemiological dynamics of antimonial resistance in Leishmania donovani: genotyping reveals a polyclonal population structure among naturally-resistant clinical isolates from Nepal.
Laurent T; Rijal S; Yardley V; Croft S; De Doncker S; Decuypere S; Khanal B; Singh R; Schönian G; Kuhls K; Chappuis F; Dujardin JC
Infect Genet Evol; 2007 Mar; 7(2):206-12. PubMed ID: 17010679
[TBL] [Abstract][Full Text] [Related]
38. Mutations in an Aquaglyceroporin as a Proven Marker of Antimony Clinical Resistance in the Parasite Leishmania donovani.
Potvin JE; Leprohon P; Queffeulou M; Sundar S; Ouellette M
Clin Infect Dis; 2021 May; 72(10):e526-e532. PubMed ID: 32827255
[TBL] [Abstract][Full Text] [Related]
39. Antimony susceptibility of Leishmania isolates collected over a 30-year period in Algeria.
Eddaikra N; Ait-Oudhia K; Kherrachi I; Oury B; Moulti-Mati F; Benikhlef R; Harrat Z; Sereno D
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006310. PubMed ID: 29561842
[TBL] [Abstract][Full Text] [Related]
40. Over-Expression of Cysteine Leucine Rich Protein Is Related to SAG Resistance in Clinical Isolates of Leishmania donovani.
Das S; Shah P; Tandon R; Yadav NK; Sahasrabuddhe AA; Sundar S; Siddiqi MI; Dube A
PLoS Negl Trop Dis; 2015 Aug; 9(8):e0003992. PubMed ID: 26295340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
